One-step vs. two-step RT-PCR: Which should you choose?
RT-PCR, the laboratory technique that adds reverse transcription to the already game-changing polymerase chain reaction technology, can be overwhelming [...]
When Will Multiplex Tissue Imaging Start Being Used as a Clinical Tool?
The field of multiplex tissue imaging has been growing quickly over the last few years with a focus on [...]
Antibody Validation and the Visikol Multiplex Platform
In the 21st century, modern medicine has become more and more complex with an ever-growing need for researchers to [...]
An Introduction to ImageJ Macros
When performing research, it is common to analyze multiple replicates per group in order to gain statistical significance in [...]
Mouse Brain Slices for Tissue Clearing Sample Preparation
Visikol began as a products-oriented company with the development of the Visikol® tissue clearing reagents back in 2012. Since [...]
HUREL Micro Liver Overview Webinar
Visikol's CEO Michael Johnson, Ph.D. gives an overview of Visikol's HUREL Micro Liver products and services. [...]
Visikol to present at SELECTBIO’s December 2021 Conference
Visikol's Director of Drug Discovery, Peter Worthington Ph.D., to Present at SELECTBIO's 3D-Cell Culture, Organoids, and Organs-on-Chips Conference [...]
Visualizing the Benefits of 3D Cell Culture Webinar
Visualizing the Benefits of 3D Cell Culture Presented by Genetic Engineering & Biotechnology & Corning Broadcast Date: November 5, 2021 [...]
HUREL Models Assist in the Evaluation of Hepatoxicity
Many drug candidates fail during clinical trials and post-market withdrawal due to hepatoxicity or Drug Induced Liver Injury (DILI). [...]
HUREL Model Micro Livers and Hepatitis B
While hepatitis B infection is preventable by a well-established vaccine, the disease has proven to be [...]